Genome Damage in Oropharyngeal Cancer Patients Treated by Radiotherapy

August 2008
Croatian Medical Journal;2008, Vol. 49 Issue 4, p515
Academic Journal
No abstract available.


Related Articles

  • Transdermal Buprenorphine for Oropharyngeal Mucositis-Associated Pain in Patients Treated with Radiotherapy for Head and Neck Cancer. Huscher, Alessandra; De Stefani, Agostina; Smussi, Ilaria; Borghetti, Paolo; Pasinetti, Nadia; Bonetti, Bartolomea; Magrini, Stefano M. // Journal of Palliative Medicine;Apr2010, Vol. 13 Issue 4, p357 

    A letter to the editor is presented about the efficacy of transdermal buprenorphine for Oropharyngeal Mucositis-associated pain in patients treated with radiotherapy for head and neck cancer.

  • Radiotherapy and Concurrent Chemotherapy: a Strategy That Improves Locoregional Control... Forastiere, Arlene A.; Trotti, Andy // JNCI: Journal of the National Cancer Institute;12/15/99, Vol. 91 Issue 24, p2065 

    Editorial. Provides information on a report that compared radiotherapy and concurrent chemotherapy versus radiotherapy alone in patients with oropharyngeal cancer. Defining patient eligibility based on resectability; Information on disease-related mortality; Effectiveness of radiochemotherapy...

  • LUNG CANCER DRUG MAY HELP TREAT ORAL CANCER.  // Journal of the American Dental Association (JADA);Feb2004, Vol. 135 Issue 2, p152 

    Reports on the possibility of using Gefitinib, a drug approved to treat advanced non-small-cell lung cancer in patients who have received chemotherapy, to treat oral cancer. Process by which the drug helps treat cancer; Effect of Gefitinib on patient response to radiotherapy in oropharyngeal...

  • Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features. Su, William; Liu, Jerry; Miles, Brett A.; Genden, Eric M.; Misiukiewicz, Krzysztof J.; Posner, Marshall; Gupta, Vishal; Bakst, Richard L. // PLoS ONE;12/8/2016, Vol. 11 Issue 12, p1 

    Background: Current standard of care for oropharyngeal cancers with positive surgical margins and/or extracapsular extension is adjuvant chemoradiotherapy. It is unknown whether HPV+ oropharyngeal cancer benefits from this treatment intensification. Objective: To investigate the outcomes of...

  • Outcome of transoral robotic surgery for stage I-II oropharyngeal cancer. Loon, J.; Smeele, L.; Hilgers, F.; Brekel, M. // European Archives of Oto-Rhino-Laryngology;Jan2015, Vol. 272 Issue 1, p175 

    Traditionally T1-2N0 oropharyngeal carcinoma is treated with a single treatment modality, being either radiotherapy or surgery. Currently, minimally invasive surgery, such as transoral robotic surgery (TORS), is gaining popularity. The aim of this study is to assess whether T1-2N0 oropharyngeal...

  • Candidoses oropharyng�es (COP) et cancers solides. Gligorov, J.; Slama, L.; Dellamonica, P.; Demard, F.; Gangneux, J.; Huttenberger, B.; Serin, D.; Luporsi, E.; Spielmann, M.; Falandry, C.; Cur�, H.; Moureau-Zabotto, L.; Barry, B.; Namer, M. // Oncologie;Apr2011, Vol. 13 Issue 4, p167 

    Oropharyngeal candidiasis (OPC) is a common infection in cancer patients. Its burden is underestimated compared to antineoplastic treatments that are risk factors: chemotherapy, radiotherapy, corticosteroids. Multidisciplinary specialists (oncologists, mycologists, infectious disease...

  • Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Sourami, R.L.; Geddes, D.M.; Spiro, S.G.; Harper, P.G.; Tobias, J.S.; Mantell, B.S.; Fearon, F.; Bradbury, I. // British Medical Journal (Clinical Research Edition);6/2/1984, Vol. 288 Issue 6431, p1643 

    Examines cell cancer of the lung treated with combination of radiotherapy and chemotherapy. Categorization of the responses of the patient treated; Effects of the radiotherapy according to the disease and quality of chemotherapy; Significance of the thoracic radiotherapy on patients survival.

  • HPV-associated oropharyngeal cancer had favorable prognosis. Cona, Christen; Harris, Jason; Southall, Jennifer // Hem/Onc Today;10/10/2010, Vol. 11 Issue 19, p32 

    This article discusses a study which examined the prognostic importance of p16 and human papillomavirus (HPV) expression in patients with oropharyngeal cancer treated with concurrent chemoradiotherapy.

  • Complications in the treatment of oropharyngeal carcinoma in patients with systemic sclerosis: A case report. ČOČEK, ALES; HAHN, ALES; AMBRUŠ, MILOSLAV; VALEŠOVÁ, MARIE // Oncology Letters;2015, Vol. 9 Issue 1, p25 

    Systemic sclerosis is a chronic, progressive disease with an extremely poor prognosis. The incidence of malignant tumors in patients with systemic sclerosis is increased when compared with that of the general population. In certain malignancies, systemic sclerosis presents as a paraneoplastic...

  • Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Lee, Haidy; Havrila, Carole; Bravo, Vikki; Shantz, Kellie; Diaz, Kellie; Larner, James; Read, Paul // Supportive Care in Cancer;Mar2008, Vol. 16 Issue 3, p285 

    Goals Malnutrition in the head and neck cancer population is a widely recognized factor contributing to negative outcomes. The goal of this study was to determine if providing complimentary oral nutritional supplementation for patients undergoing definitive radiation therapy for oropharyngeal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics